US Stock MarketDetailed Quotes
INAB In8bio
- 0.319
- -0.049-13.26%
Close Dec 3 16:00 ET
- 0.340
- +0.021+6.52%
Post 18:48 ET
23.14MMarket Cap-431P/E (TTM)
0.365High0.315Low1.34MVolume0.358Open0.368Pre Close443.68KTurnover2.48%Turnover RatioLossP/E (Static)72.48MShares2.48052wk High2.71P/B17.32MFloat Cap0.21752wk Low--Dividend TTM54.25MShs Float10.319Historical High--Div YieldTTM13.48%Amplitude0.217Historical Low0.330Avg Price1Lot Size
About In8bio Company
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Company Profile
SymbolINAB
Company NameIn8bio
Listing DateJul 30, 2021
Issue Price10.00
Founded2016
CEOMr. William Ho
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address350 5th Avenue,Suite 5330
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone1-646-600-6438
Websitehttp://www.in8bio.com
Company Executives
- Name
- Position
- Salary
- William Ho
- Director, President and Chief Executive Officer
- 1.85M
- Patrick McCall
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 914.84K
- Dr. Lawrence Lamb, PhD
- Executive Vice President and Chief Scientific Officer
- --
- Dr. Kate Rochlin, PhD
- Chief Operating Officer
- --
- Alan S. Roemer
- Chairman of the Board
- 256.42K
- Dr. Corinne Epperly, PhD
- Director
- 48.87K
- Dr. Jeremy Graff, PhD
- Director
- 211.18K
- Emily Wang Fairbairn
- Independent Director
- 172.92K
- Peter C. Brandt
- Independent Director
- 195.42K
- Travis Whitfill
- Independent Director
- 163.67K
- Luba Greenwood
- Independent Director
- 181.42K
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
